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Abstract 
Obesity is a growing concern in the United States, and the effects of extra body mass puts 
multiple strains on all different body systems and body parts. Those who are obese are more 
likely to develop osteoarthritis at a quicker rate than those who are not obese; also placing them 
at an increased risk to need a joint replacement (Arthritis Foundation, 2020). Throughout the 
orthopedic literature there is consensus and vast evidence that increasing body mass index and 
obesity are correlated with poor clinical outcomes post total joint arthroplasty; though, there is 
no agreement on at what threshold of body mass index does the risks of surgery outweigh the 
benefits. The literature review was conducted using both CINAHL and PubMed databases. 348 
articles were initially identified. English language, five years old or less, and peer reviewed were 
used as limitations. Key words included: “body mass index threshold of 40” AND “total joint 
replacement”, “BMI parameters” AND “knee replacement”, “body mass index threshold of 40 
and total joint replacements”, and “body mass parameters and total joint replacements.” This 
reduced articles to 16. Upon further review, 10 were identified as relevant for this review. The 
case study and literature review will demonstrate the effect of obesity on clinical outcomes in 
total joint replacement patients, highlighting that a body mass of greater than 40 is correlated 
with poor clinical outcomes and can serve as the new threshold to guide patients and surgeons to 
make an informed and educated decision on management of osteoarthritis in morbidly obese 
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Background 
Obesity has become a public health crisis in the United States, around 35% of the adult 
population is obese (Martin et al., 2017).  Obesity is classified as a body mass index (BMI) of 
greater than 30kg/m, there are several different classes of obesity including class 1 (30-34.9), 
class II (35-39), and class III or morbid obesity which is BMI greater than 40 (Martin et al., 
2017). Obesity often affects our body parts and systems; those with obesity are more likely to 
suffer from multiple comorbidities as well. Obesity strains the joints both mechanically and 
physiologically which ultimately progresses to the development of osteoarthritis. Greater weight 
from obesity and high body mass index puts greater force and impact on articular cartilage, 
leading to articular cartilage inflammation and destruction or osteoarthritis. These physiological 
changes often result in a need for total joint replacements. With the greater impact of force and 
weight on the joints of those who are obese there is a higher incidence of osteoarthritis thus 
leading to an increase in total joint replacements in this population (Springer et al., 2013). 
Springer et al. (2013) found that when compared to non-obese patients those with a BMI greater 
than 40 are nearly ten times more prone to need a total hip replacement.  
Martin et al. (2017) found a strong correlation with obesity and worse clinical outcomes 
in patients who had total knee replacements than those who are not obese. Furthermore, it was 
found that when BMI trends into the morbid and super-obese classification complication rates of 
total joint replacements rise including infection and an increase in rates of reoperation and 
revision. In 2013 a workgroup of the American Association of Hip and Knee Surgeons Evidence 
Based Committee (Springer et al., 2013) performed a literature review on obesity and total joint 
arthroplasty. One of the group’s main focus was facilitating and supplementing the patient-
surgeon discussion along with provoke further research on the topic. Research clearly identifies 
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increased risks associated with obesity and total joint replacements; however, it is difficult to 
specifically quantify given obese patients often have other comorbidities such as diabetes or 
heart disease (Springer et al., 2013).  
Currently there is not one specific clinical guideline that endorses a specific BMI 
threshold for postponing total joint arthroplasty. According to Orthoguidelines (2015) there is 
evidence that supports obese patients have less improvement in outcomes post total knee 
arthroplasty and identify they have increased risk of periprosthetic joint infection. Additionally, 
patients with a BMI greater than 40 should be advised of their risk of less improvement in 
functional outcomes post TKA. Springer et al. (2013) reported findings that morbidly obese 
(BMI >40) and super obese (BMI>50) have surgical complications that offset the benefits of 
total joint arthroplasty including infection and increased revision rates. Additionally, it was 
indicated in those who are need of a total joint replacement who have a BMI greater than 40 
there should be reconsideration to delay surgery. There was also a call for the further need of 
research on the impact of obesity on total joint arthroplasty. Since the Springer et al. (2013) 
article years seven ago there has been a lack of updated evidence along agreement on what exact 
body mass index should serve as a threshold for poor clinical outcomes in total joint replacement 
patients. Up to date evidence could help guide health care professionals to make decisions 
regarding morbidly obese patients and total joint arthroplasty.  
The case report referenced in the appendix will introduce 46-year-old female who has a 
history of obesity (BMI 34), hypertension, diabetes type II, and hypothyroidism who presents for 
a preoperative evaluation. This patient fell six months ago and is in need of a surgical repair for 
her right meniscus. With the patient’s current body mass index of 34, she is classified as obese. 
With her obesity history, she is at an increased risk of developing osteoarthritis and the need for 
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total joint replacement. The case study and literature review will demonstrate the effect of 
obesity on clinical outcomes in total joint replacement patients, along with highlight the clinical 
role of the nurse practitioner in the management of this case. 
Literature Review 
Literature Search 
Databases during the initial literature search involved two databases of CINAHL and 
PubMed via the University of North Dakota’s Medical School Library to investigate articles and 
resources on the topic of obesity and total joint replacements. Parameters for all searches 
included only English language and a date range of 2015-2020. The original search for literature 
in CINAHL involved key words of “obesity” AND “knee replacement” which total 249 articles; 
the next search involved “body mass index” AND “total joint replacements” which elicited 255 
articles. To narrow results the next search used “body mass index threshold of 40” AND “total 
knee replacement” generated five articles, “body mass index threshold of 40” AND “total joint 
replacement” generated seven articles, and “BMI parameters” AND “knee replacement” 
produced 26 articles. PubMed generated very similar results when using terms of “body mass 
index threshold of 40 and knee replacement” generated seven articles, “body mass index 
threshold of 40 and total joint replacements” produced eight articles, and “body mass parameters 
and total joint replacements” gave 93 articles to review. There was also review of reference 
sections on the articles discovered from the most specific searches. A total of 16 articles were 
chosen for further examination based on the performed literature review. The reference lists of 
these articles were also examined for additional resources. 10 articles were finally selected for 
the literature review of this paper. The six articles were discarded due to not directly citing a 
body mass index of 40 having the direct effect on clinical outcomes in total joint replacements.  
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Topic Formulation  
Obesity is an epidemic affecting the United States of America, as one-third of the United 
States population is considered overweight or obese (Alvi et al., 2015). The Arthritis Foundation 
(2020) cites the increased prevalence of osteoarthritis is directly correlated to the increase in 
obesity in our country. Springer et al. (2013) found that the likelihood of having knee 
osteoarthritis is four times in obese men and five times in obese women. There is a direct 
correlation with obesity and osteoarthritis in the literature. The rate of progression is often 
compounded by one’s obesity placing these individuals at a higher need of joint replacement 
while also putting them at danger of complications and worse outcomes post-surgery (Arthritis 
Foundation, 2020). Morbid obesity has been correlated with early surgical complications post 
total joint arthroplasty including thromboembolic events and wound infections (Wagner et al., 
2016).   
Obese persons have increased rates of osteoarthritis often leading to total joint 
replacement consideration (Springer et al., 2013). Nearly half the patients who get a primary 
total knee replacement and around one third of those who get a total hip replacement are obese 
(Lubekke et al., 2016). A workgroup of the American Association of Hip and Knee Surgeons 
Evidence Based Committee looked to evaluate obesity and total joint arthroplasty. It was 
discovered that a BMI greater than 40 or morbidly obese appeared to be the threshold where 
perioperative complications such as infection and revision rates dramatically increased in total 
knee arthroplasty (TKA) The recommendation was also then suggested to be used in patients 
requiring total hip arthroplasty (THA). The committee calls for further research and evidence to 
assess the exact threshold of BMI in total joint replacements and the effect of obesity on total 
joint replacement outcomes (Springer et al., 2013). According to Lubbeke et al. (2016) the 
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current literature on obesity categories and the outcome of infection only compares above and 
below a BMI of 30. Shohat et al. (2018) cited inconsistency in the literature for a threshold on 
BMI and the risk for infection that can outweigh the benefits of surgery.  
Synthesis of Current Literature  
This case study involved a 46-year-old female patient who presented for preoperative 
evaluation for a meniscus repair. When examining the overall case study of this 46-year-old 
female who has a BMI of 34 and is considered obese, she is at risk for the future development of 
osteoarthritis and there is a well-known link between obesity and osteoarthritis requiring total 
joint replacement (Alvi et al., 2015). A body mass index of greater than 40 has been cited in the 
literature as a potential threshold for poor outcomes post total joint arthroplasty but further 
research was needed to solidify this threshold. In this synthesis of current literature, we are 
examining the association of BMI greater than 40 and the risk of poor clinical outcomes in total 
joint arthroplasty.  
 Alvi et al. (2015) is the novel study highlighted by OrthoGuidelines (2015) which 
emphasized the fact that those with a BMI greater than 40 had increased morbidity including 
greater rates of medical complications, surgical complications, and surgical site infections. In 
this study 13,250 patients from the American College of Surgeons-National Surgical Quality 
Improvement Program data base from the years of 2005-2011 were put together to evaluate the 
effect of BMI on perioperative outcomes in THA/TKA patients using a nationally representative 
cohort using matched multivariable statistical analysis to help control for confounders such as 
comorbidities, age, or smoking status. There is particular evidence of the greater infection rates 
in this population. Alvi et al. (2015) cited specifically that those with a BMI greater than 40 were 
associated with increased surgical site infections and a particularly increased risk of superficial 
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wound infection. Si et al. (2015) adds additional evidence when they reported a BMI greater than 
40 serves as a threshold for the greatest risk of deep infection post total joint arthroplasty. 
Lubbeke et al. (2016) compared the incidence of BMI and prosthetic joint infections and 
discovered the rate of infections for normal weight was 1.8 cases per 1,000 persons 
comparatively to the obese class III the rate was 6.7 cases per 1000 persons. Wagner et al. (2016) 
large consecutive series concluded that those with greater BMIs coincided a more advanced risk 
especially at the mark of a BMI of 40 or greater. When paralleled with a BMI of 18-24 the 
patients with a BMI greater than 40 had double the risk of superficial or deep wound infection, 
while also an amplified risk of deep periprostatic infection (Wagner et al., 2016).  
Shohat et al. (2018) set out to discover if there is a BMI cutoff threshold that is associated 
with increased risk for joint infection through a retrospective study of primary total hips and total 
knees between 2006-2015 with 18,173 patients. Shohat et al. (2018) verified BMI as an 
independent risk for prosthetic joint infection. Of particular note was at the 90-day post-surgery 
mark the only patients who were at higher risk of prosthetic joint infection was the obesity class 
III or BMI greater than 40. The BMI greater than 40 group had a threefold increased risk thus 
Shohat et al (2018) recommended that benefits and risks must be measured in this group prior to 
surgery. Kandil et al. (2015) adds even further evidence when they reported the morbidly obese 
group was also linked to considerably increased rates of infection when compared to obese or 
non-obese groups. Different categories of infection have been documented throughout the 
literature that are correlated with increasing BMI. Si et al. (2015) linked increasing BMI to 
increased rates of any infection, while the cut off of BMI > 40 served as the threshold for the 
greatest risk of developing a deep infection. Si et al. (2015) aimed to bring the threshold even 
further down when they called attention to their results that the BMI of 30 cut off serves as a 
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threshold in which patients begin to have increased risk of infection following TKA. Pugely et 
al. (2015) reported in their large review of the American College of Surgeons National Surgical 
Quality Improvement database during the years 2005-2010 in the total joint arthroplasty cohort 
the patient’s BMI was the highest risk factor for 30-day surgical site infection, this risk was 
greater in those with a BMI > 40.  There is a clear correlation in the literature  reviewed that a 
BMI of greater than 40 has a significant effect and correlation on the risk of infection in total 
joint arthroplasty (Alvi et al., 2015; Kandil et al., 2015; Lubbeke et al., 2016;  Meller et al., 2016; 
Pugely et al., 2015; Si et al., 2015; Shohat at et., 2018; Wagner et al., 2016).  
Infection is not the only poor clinical outcome that is connected to the morbidly obese 
population undergoing total joint replacement. Throughout the literature surgical complications 
are correlated with a BMI greater than 40. Alvi et al. (2015) reported that a body mass of greater 
than 40 had greater rates of returning to the operating room (OR) and longer OR to discharge 
times. Lubbeke et al (2016) agreed with these findings when they cited that those with a BMI 
greater than 40 were more likely to have surgery greater than 180 minutes. Meller et al. (2016) 
cited that morbidly obese patients were more at risk for complications such as wound 
dehiscence. Additional surgical complications in the morbidly obese demographic include the 
increased risk of reoperation, component failure, and implant revision or removal. The risk of 
revision related to mechanical failure due to aseptic loosening and polyethene wear was 
correlated with BMI, while the peak of this risk was at a BMI of 40 (Wagner et al., 2016). 
Christensen et al. (2018) determined that increasing BMI was linked to greater association of 
implant revision or removal, with a 19% increase in revision need for any reason per one 
standard deviation increase in BMI (Christensen et al., 2018). Most notable was the peak in rise 
of risk for revision due to mechanical failure and for aseptic loosening was at a BMI of 40. 
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Sayed-Noor et al. (2019) solidified the surgical risks and complications when they reported that 
the morbidly obese have double the risk of reoperation or revision. Pugeley et at. (2015) cited 
that not only was the morbidly obese patient more likely to have revision, they had an increased 
risk of surgical site infection after their revision as well. The surgical complications associated 
with a BMI greater than 40 in total joint arthroplasty are clearly documented and correlated in 
the literature (Alvi et al., 2015; Christensen et al., 2018; Lubbeke et al., 2016; Meller et al., 2016; 
Pugeley et al., 2015; Sayed-Noor et al., 2019; Wagner et al., 2016).  
The literature consistently references that a BMI of greater than 40 is associated with 
clinically poor outcomes post total joint arthroplasty. There is particular evidence in the literature 
correlating significant medical complications on top of infection in those patients undergoing 
total joint arthroplasty who are morbidly obese. Shohat et al. (2015) concluded that this group 
has a threefold increase risk of complications. Alvi et al. (2015) cited that the obesity class III or 
a BMI greater than 40 was linked to increased morbidity when compared to those of normal 
weight or overweight. Kandil et al. (2015) aimed to look at obesity and morbid obesity and their 
related medical comorbidities with their association of increased complications post 
unicomparmental knee arthroplasty. Obese (BMI 30-39) and morbidly obese (BMI >40) patients 
who underwent TKA had increased rates of major complications (PE, DVT, MI, post-operative 
I&D, respiratory failure) within 90 days after surgery, while the morbidly obese were 3 times 
more at risk of developing major and minor (UTI, renal failure, blood transfusion, stiffness) 
complications. Morbid obesity was associated with increased rates of local complications when 
compared to those who were obese or not obese, medical complication frequencies were also 
significantly higher in the morbidly obese versus the obese. Meller et al. (2016) added additional 
evidence with a cited relationship between rising BMI and the risk of developing renal failure 
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after total joint replacement. Si et al. (2015) provided further medical complication evidence 
when it was reported the rate of deep vein thrombosis increased amongst their morbidly obese 
population undergoing TKA. There is a clear correlation throughout the articles reviewed that a 
BMI of greater than 40 has a significant effect and correlation on the risk of developing medical 
complications after total joint arthroplasty (Alvi et al., 2015; Kandil et al., 2015; Meller et al. 
2016; Shohat et al., 2015; Si et al., 2015).  
Alvi et al. (2015) indicated that a BMI greater than 40 puts a morbidly obese patient at an 
increased risk of complications post total joint arthroplasty when compared to normal weight and 
overweight patients. Pugely et al. (2015) cited that a BMI greater than 40 was linked with a odds 
ratio of 1.9 risk of higher complications post total joint arthroplasty. The stratified risk of 
infection, medical complications, and surgical complications correlated throughout the literature 
adds additional negative outcomes on the morbidly obese patient undergoing total joint 
replacements. Morbidly obese patients receiving total joint arthroplasty were also associated with 
increased cost related to their increased morbidity (Meller et al., 2016). These associated costs 
are highlighted through the literature and are due to higher rates of readmission, infection, 
complications, and component failures. Meller et al. (2016) reported that morbidly obese total 
joint patients are 15% more likely to return to the hospital within 90 day after their operation. 
With the documented complications and risks it is not a surprise when Sayer-Noor et al. (2019) 
documented that a BMI of greater than 40 had higher mortality rates at the 90-day mark after 
total joint arthroplasty.  
Evidence found throughout the literature consistently reveals the poor clinical outcomes 
associated with those patients undergoing total joint replacement with a concurrent BMI greater 
than 40. A BMI greater than 40 was connected to medical complications, surgical complications, 
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and surgical site infection when compared to BMI less than 25 and overweight individuals (Alvi 
et al., 2015). Currently, there is no standard threshold amongst the orthopedic community on 
body mass index and total joint arthroplasty. There is a clear correlation with higher risk of 
infection, medical complications and surgical complications such as the need for revision or 
reoperation in the morbidly obese population undergoing total joint arthroplasty. Shohat et al. 
(2018) stated the BMI greater than 40 group had a threefold increased risk of complications thus 
benefits and risks must be measured in this group in regards prior to surgery. With this in mind 
Pugely et al. (2015) suggested surgeons discuss with obese patients these risks and caution 
elective surgery. The orthopedic surgeon should have an honest discussion with the morbidly 
obese patient about risks and benefits of the surgery.  
The literature provides well documented ill effects of raising BMI associated with poor 
clinical outcomes in total joint arthroplasty patients. This provides an opportunity for further 
research on what the optimal BMI to perform joint replacements, as the max threshold (BMI of 
40) for detrimental outcomes has been concluded in the literature. More research is needed on 
total hip arthroplasty and the effect of body mass index, as many of the studies were dominated 
by total knee arthroplasty. Ultimately, a body mass index of greater than 40 does correlate with 
poor clinical outcomes in total joint arthroplasty patients and can serve as a threshold to help 
guide the patient and surgeon on determining the risks and benefits of total joint arthroplasty.  
Learning Points 
• Obesity is a risk factor for the development of osteoarthritis. Those who are obese 
are at an increased risk to need a joint replacement while being at danger of 
complications and worse outcomes post-surgery. Those who are obese also have 
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co-existing comorbidities which influence surgery and healing, this only adds 
further complication risks and increased risks to surgery.  
• As BMI increases so does the risks of undergoing total joint arthroplasty. The 
peak of the complications rises at the threshold of BMI greater than 40. These 
complications include higher rates of infection (superficial, deep, or prosthetic), 
revision, reoperation, mechanical failure, medical complications, and surgical 
complications. There is agreement amongst the evidence linking the risk of 
infection to a body mass greater than 40 in patients undergoing total joint 
arthoplasty. 
• A body mass index of greater than 40 does correlate with poor clinical outcomes 
in total joint arthroplasty patients and can serve as a threshold to help guide the 
patient and orthopedic surgeon on determining the risks and benefits of surgery.  
• More research is needed on total hip arthroplasty and the effect of body mass 
index, as many of the studies were dominated by total knee arthroplasty. If a BMI 
of greater than 40 is correlated with poor clinical outcomes, further research is 
needed to find the appropriate BMI threshold correlated with the best outcomes 
for total joint replacements in obese patients.  
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Appendix: Case Report 
T. Smith is a 46-year-old female patient with a history of hypertension, obesity, diabetes 
type 2, hypothyroidism, and squamous cell skin carcinoma. She presents for a preoperative exam 
for right knee arthroscopy for meniscal tear. She fell six months ago which caused injury to the 
right knee. She reports this was just an accident when she slipped and fell, no medical cause for 
the fall. She has been doing well since the injury but still is having pain with activity to the right 
knee. She has been using ibuprofen 600mg TID and Tylenol 1000mg TID for her pain. There is 
no numbness or tingling to the right lower extremity, nor to her other extremities. She denies any 
weakness or the knee giving out.  She denies any recent illness. She denies fevers, sore throat, or 
cough. She denies shortness of breath, chest pain, or palpitations. Denies leg swelling. There has 
been no recent nausea, vomiting, or diarrhea. No concerns with her bowels or urination. She 
denies rash. She reports she does not check her blood sugars or blood pressures, though 
previously they have all been well controlled. She also reports her thyroid has remained within 
normal limits in the past.  
She reports she is able to climb several flights of stairs with no issue along with walk 
several city blocks with no shortness of breath or chest pain. She does not do any particular 
exercise program but reports she does stay active with walking.  She is a former 1 pack per day 
smoker for 20 years which she quit several years ago and rarely drinks. No illicit drug use. She 
has tolerated surgery and anesthesia well in the past with a previous hysterectomy and two c-
sections. She denies a history of bleeding or clotting tendencies. No adverse events to anesthesia 
in her family history. 
T. Smith reports she is on Lisinopril 10mg, ASA, Metformin 1000mg BID, Rybelsus 
7mg daily, Aspirin 81mg daily, and Synthroid 125mcg. She has taking Tylenol and Ibuprofen as 
OBESITY AND TOTAL JOINT REPLACEMENTS 19 
needed for pain. She is tolerating these medications well, and reports her blood pressure, blood 
sugar, and thyroid have been well controlled. She is unsure what her last A1C was. She is 
allergic to amoxicillin and morphine. Her pertinent family history includes a father who has a 
history of coronary artery disease with three stents at age 55 along with hypertension and 
hyperlipemia. Her mother suffers from hypertension, obesity, and breast cancer at 60. Her 
brother and sister are doing well and in good health.  
Once a history was obtained from T. Smith a comprehensive physical exam was 
completed. T. Smith’s vital signs at the visit included: BP 136/88, HR 78, RR 16, Temp 98.5 F, 
and 95% oxygen saturation. Today she weighs 211 pounds with a BMI of 34. She is a pleasant 
46-year female who is alert and oriented with proper gait. Her pupils are equal, round, and 
reactive to light, upon fundoscopic exam there is a red reflex bilaterally with clear fundi and no 
arteriovenous nicking or retinopathy.  Her tympanic membranes are normal bilaterally. Her 
thyroid is nonpalpable, there is no cervical adenopathy. Her posterior pharynx is clear with no 
drainage or tonsillar hypertrophy. Her Mallampati class would be considered a I, there are no 
missing teeth, nor does wear dentures.  She can open her mouth to 3-4 finger breadths and has 
full range of motion to her neck.  Her cardiac assessment reveals a normal heart rate and rhythm, 
S1 and S2 were heard with no extra heart sounds, murmurs, rubs, or gallops.  There are no 
carotid bruits or thrills. Her radial, tibial, and dorsalis pedis pulses are equal and plus +2 
bilaterally. There is no jugular venous distention or peripheral edema.  Her respiratory exam 
reveals clear lung sounds to auscultation that are even with non-labored respirations.  Her 
abdominal exam reveals a soft, non-distended, and non-tender abdomen with normal bowel 
sounds. Her neurologic exam discloses cranial nerves are 2-12 intact and normal, she has full 
equal sensation and strength to all four extremities. There is no rash or wound to her skin. The 
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right knee shows no redness, swelling, and is non tender. Diabetic foot exam reveals some 
callousing to her heels with no wounds with normal monofilament testing to her bilateral feet.  
With her history of diabetes, obesity, hypertension, and hypothyroidism along with her 
father having a cardiac event and stents at 55 we did perform several pre-operative labs today 
which are as follows: TSH 3.65,  a BMP which was within normal limits, notable a creatinine of 
0.8, glucose 98, albumin 3.9, and potassium 4.0, a normal CBC including a hemoglobin of 14.6, 
prior AIC’s have been well controlled per patient, and a EKG showing normal sinus rhythm.  
T. Smith’s revised cardiac risk index for preoperative risk is a class 1 risk. Her ARISCAT 
score for postoperative pulmonary complications is low risk.  She is able to meet greater than 4 
METS. Therefore, her functional capacity is well. Based on T. Smith’s medical history, tolerance 
of previous surgery, physical exam, and lab results we will clear her for surgery and confirm her 
as a low- moderate risk for surgery. Educated to follow her orthopedic surgeon instructions on 
medications. She is okay to take her daily medications but should stop taking ibuprofen and her 
aspirin 5-7 days prior to surgery, Tylenol is okay. She is instructed to avoid any new 
supplements as well. She is agreeable to this plan. She may continue to use her medications post 
operatively, she may have to avoid her ibuprofen, but her aspirin could provide benefit for DVT 
prophylaxis. She should follow the instructions of her orthopedic surgeon.  
In regard to a plan and recommendations, we did discuss T. Smith’s weight today. 
T.Smith’s BMI is 34 classifying her as obese. We discussed the risk factor of obesity with the 
incidence of osteoarthritis leading to the need of a total joint replacement in the future (Springer 
et al., 2013). Per Springer et al. (2013) obese patients with a BMI greater than 30 have an 
increased risk of perioperative complications and this risk should be addressed with the patient 
before contemplating total joint replacements.  If T.Smith’s BMI was to increase to greater than 
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40 threshold the perioperative implications will only increase such as infection, questionable 
functional improvements, and increased revision rates (Springer et al., 2013). T. Smith is open to 
this discussion. She is willing after her meniscus repair to start physical therapy and achieve 
regular exercise of at least 30 minutes five days a week once she is healed. We did discuss the 
idea of a referral to the diabetic educator and weight management program to initiate weight loss. 
She is open to both of these referrals; we did place them today. We will follow up 2 months after 
surgery to make sure she is getting on track with these referrals and to ensure she is rehab. 
Encouraged her to start tracking her blood pressures, blood sugars, and weights. Continue her 
medication regimen. She will contact the clinic sooner for any issue at all. She is agreeable to the 
plan and all questions answered.  
 
